Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.779 USD | +1.30% | +2.50% | +5.99% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.99% | 21.04M | |
+3.07% | 103B | |
+1.57% | 30.28B | |
+9.74% | 21.76B | |
-18.77% | 17.18B | |
-6.03% | 17.71B | |
+1.54% | 14.26B | |
-6.43% | 12B | |
-2.98% | 10.39B | |
-10.66% | 8.86B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 : ' Identified Technologies Gets $500,000 in Drone Mapping Contracts